ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 37 of 68
УЖМБС 2021, 6(5): 263–269
Clinical Medicine

Investigation of the Adherence to Prescribed Treatment of the Patients with Coronary Heart Disease

Shuper V. O.1, Shuper S. V. 2, Trefanenko I. V.1, Shumko G. I.1, Reva T. V.1

The purpose of the study was to investigate the adherence to secondary prevention medications among patients with coronary heart disease and identify factors associated with it. Materials and methods. We examined 40 patients diagnosed with coronary heart disease of more than 50 years old, who were prescribed with optimal medication for 1 year during hospitalization. Patients` adherence was defined according to MMS-8 Morisky values for secondary prevention medications prescribed by doctors. Also, questionnaires about individual reasons of non-compliance and for individual patient`s opinion about importance and usefulness of knowledge according to risk factors of the increase of cardiovascular mortality were designed and proposed to the patients. Simple descriptive statistics were used to elucidate the characteristics of the patient population and results from individual adherence tools. Final score was analyzed and correlation between patients’ data and level of adherence to prescribed treatment were identified. A correlation matrix (using Spearman’s coefficient) was reviewed for any evidence of collinearity. Results and discussion. Our study demonstrated higher level of non-adherence with secondary prevention medications in patients with coronary heart disease (60.0%). This fact can be explained by the socioeconomic reasons, less informative strategies from the medical staff to the patients. Severe regress of adherence was demonstrated after discharge from the hospital due to subjective improvement of the patients` condition with absence of supervision by out-patient specialists. Demographic characteristics of the patients suggested that some non-modified factors can affect compliance with the prescribed treatment. Better adherence was demonstrated by female married patients with higher educational level, with family history about cardiovascular death. Also, too much prescribed medications with difficult regime of usage with non-adequate out-patient supervision may significantly decrease adherence causing development of complications which may lead to re-hospitalizations and cardiovascular death. Our investigation demonstrated also non-complete information of the patients about lifestyle and medical risk factors of the cardiovascular mortality increase. Conclusion. The results of our study can provide useful practical information on the prevalence and severity of non-adherence among patients with coronary heart disease. Analysis of the factors influencing the adherence demonstrated the main reasons from patients and healthcare professionals affecting the level of compliance with the prescribed treatment. The step towards improving adherence can be initiated by the healthcare professional to overcome the patient's concerns about the prescribed medication. It is important to continue personal monitoring of patients by healthcare professionals in the form of regular inspections of intentional and unintentional non-adherence, including factors and reasons that may change and lead to such behavior

Keywords: non-adherence, coronary heart disease, secondary prevention medications

Full text: PDF (Ua) 280K

  1. Bassett SM, Schuette SA, O'Dwyer LC, Moskowitz JT. Positive affect and medication adherence in chronic conditions: A systematic review. Health Psychol. 2019; 38(11): 960-74.
  2. Brown MT, Bussell JK. Medication Adherence: WHO Cares? Mayo Clin Proceed. 2011;86:304-14.
  3. Osterberg L, Blaschke T. Adherence to medication. N Eng J Med. 2005; 353(5): 487-97.
  4. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Frontiers Pharmacol. 2013; 4: 91.
  5. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication Compliance and Persistence: Terminology and Definitions. Val Health. 2008; 11: 44-7.
  6. Karimullah MDH, Rohman MS, Adriyanto T, Tjahjono CT, Widito S. Community-based Cardiac Rehabilitation Improved Adherence to Medication, Quality of Life and Rehospitalization Among Stable Coronary Artery Patients: A Cohort Study. Heart Sci J. 2020; 1(2): 24-31.
  7. Khatib R, Marshall K, Silcock J, Forrest C, Hall AS. Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers. Open Heart. 2019; 6: e000997.
  8. Tian Y, Deng P, Li B, Wang J, Li J, Huang Y, Zheng Y. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance. Rev Cardiovasc Med. 2019; 20(1): 27-33.
  9. Dhar L, Dantas J, Ali M. A Systematic Review of Factors Influencing Medication Adherence to Hypertension Treatment in Developing Countries. Open J Epidemiol. 2017; 7: 211-50.
  10. Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008; 10(5): 348-354.
  11. De Vera MA, Bhole V, Burns LC, Lacaille D. Impact of statin adherence. Br J Clin Pharmacol. 2014; 78: 684-98.
  12. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297: 177-86.
  13. Nobre M, Domingues R. Patient adherence to ischemic heart disease treatment. Rev Assoc Med Brasil. 2017; 63(3): 252-60.
  14. McHorney CA. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009; 25(1): 215-38.
  15. Santo K, Chow CK, Thiagalingam A, et al. MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol. BMJ Open. 2017; 7: e017540.
  16. Alm-Roijer С, Stagmo M, Ude G, Erhardt L. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs. 2004; 3: 321- 30.
  17. Kubica A, Kosobucka A, Fabiszak T, Gorog DA, Siller-Matula JM. Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires? Curr Med Res Opin. 2019; 35: 341-9.